About MEDRAD
MEDRAD develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services.
Want to inform investors similar to MEDRAD about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing MEDRAD
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find MEDRAD in 1 Expert Collection, including Medical Devices.
Medical Devices
3,088 items
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Latest MEDRAD News
Dec 19, 2019
FDA clears expanded use of Bayer's Medrad system Dec. 19, 2019 11:15 AM ET The FDA grants 510(k) clearance to Bayer's ( OTCPK:BAYRY +0.1%) MEDRAD Stellant FLEX Computed Tomography (CT) Injection System with Certegra Workstation for use in Contrast Enhanced Mammography (CEM). The company says the use of iodine-based x-ray contrast agents in CEM enables better visualization of abnormalities in breast tissue that standard mammography may miss.
MEDRAD Acquisitions
2 Acquisitions
MEDRAD acquired 2 companies. Their latest acquisition was Pathway Medical Technologies on September 02, 2011.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
9/2/2011 | Series E+ | $123.5M | Acquired | 1 | ||
2/11/2008 |
Date | 9/2/2011 | 2/11/2008 |
|---|---|---|
Investment Stage | Series E+ | |
Companies | ||
Valuation | ||
Total Funding | $123.5M | |
Note | Acquired | |
Sources | 1 |
MEDRAD Team
3 Team Members
MEDRAD has 3 team members, including former Chief Information Officer, Jeanne Colwell Iasella.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.